[1]
2025. Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy. Genetics and Molecular Research. 24, 1 (Jun. 2025), 1–17. DOI:https://doi.org/10.4238/z2qb9g57.